Tetrabenazine and movement disorders.
Neurology
; 31(8): 1051-4, 1981 Aug.
Article
em En
| MEDLINE
| ID: mdl-6455607
ABSTRACT
Based on blind review of videotape recordings, we analyzed the ability of tetrabenazine to suppress abnormal movements. The recordings were done before treatment, after 3 weeks on a stable dose (up to 200 mg daily) of tetrabenazine, and then after 3 weeks on placebo. Among the patients who completed the trial, improvement occurred in 6 of 8 with Huntington disease, 6 of 10 with tardive dyskinesia, and 3 of 8 with dystonic disorders. The drug was usually tolerated well.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Tetrabenazina
/
Transtornos dos Movimentos
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Neurology
Ano de publicação:
1981
Tipo de documento:
Article